AI And Chiplet Trends Will Expand Enterprise Markets

Published
28 Mar 25
Updated
08 Aug 25
AnalystConsensusTarget's Fair Value
US$14.00
35.0% undervalued intrinsic discount
08 Aug
US$9.10
Loading
1Y
31.5%
7D
-3.7%

Author's Valuation

US$14.0

35.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update08 Aug 25

With both the discount rate and future P/E multiples remaining virtually unchanged, Arteris’ consensus analyst price target also held steady at $14.00.


What's in the News


  • Arteris provided updated revenue guidance for Q3 2025 of $16.8–$17.2 million and full year 2025 of $66.0–$70.0 million.
  • AMD licensed Arteris' FlexGen NoC IP for next-generation AI chiplets, integrating with AMD’s Infinity Fabric across its AI product portfolio.
  • Whalechip licensed Arteris' FlexNoC 5 IP for a custom ASIC supporting advanced near-memory computing architectures aimed at AI applications.
  • Arteris was added to several Russell value and small-cap benchmark indexes, enhancing its visibility among investors.
  • The company launched Magillem Packaging, new software to automate and simplify chip design and IP packaging for complex SoCs and chiplets.

Valuation Changes


Summary of Valuation Changes for Arteris

  • The Consensus Analyst Price Target remained effectively unchanged, at $14.00.
  • The Discount Rate for Arteris remained effectively unchanged, moving only marginally from 8.47% to 8.50%.
  • The Future P/E for Arteris remained effectively unchanged, moving only marginally from 66.55x to 66.61x.

Key Takeaways

  • Rising AI adoption and industry shifts toward chiplet architectures are expanding Arteris' market opportunities and supporting sustained revenue growth.
  • Innovative product launches and stronger customer reliance are boosting competitive advantage, recurring revenues, and margin expansion potential.
  • Dependence on large customers, rising R&D costs, and evolving industry dynamics threaten revenue stability, profitability, and long-term growth amid ongoing macroeconomic uncertainties.

Catalysts

About Arteris
    Provides semiconductor system intellectual property solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East.
What are the underlying business or industry changes driving this perspective?
  • Accelerating adoption of AI and machine learning in enterprise computing and automotive sectors is driving higher demand for Arteris' advanced NoC IP, as evidenced by recent major wins like AMD and Whalechip; this is likely to underpin sustained revenue growth as AI workloads and system complexity proliferate across industries.
  • The ongoing industry transition to chiplet-based and heterogeneous integration architectures is expanding Arteris' addressable market, with chiplet-related design starts expected to rise from 5% to 30% in coming years; this structural trend supports both higher sales volume and increased average selling prices, benefiting future top-line revenue.
  • Arteris' launch of innovative products such as FlexGen and Magillem Packaging-recognized with industry awards and integrated into leading chipmaker portfolios-raises the technological moat, improving competitive positioning and enabling potential margin expansion through pricing power.
  • Increasing reliance by large semiconductor companies on outsourcing specialized system IP, highlighted by growing customer interest and accelerated engagements, suggests expanding recurring revenue streams and enhanced revenue visibility, which may drive more stable and predictable long-term earnings.
  • Growth in remaining performance obligations (RPO), up 28% year-over-year, signals a solid and expanding contractual revenue base, providing confidence in forward revenue realization and supporting operating leverage as R&D investments start to scale with increased deployment of Arteris' solutions.

Arteris Earnings and Revenue Growth

Arteris Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • Analysts are assuming Arteris's revenue will grow by 17.8% annually over the next 3 years.
  • Analysts are not forecasting that Arteris will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Arteris's profit margin will increase from -52.4% to the average US Software industry of 13.5% in 3 years.
  • If Arteris's profit margin were to converge on the industry average, you could expect earnings to reach $14.0 million (and earnings per share of $0.27) by about August 2028, up from $-33.1 million today.
  • In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 66.6x on those 2028 earnings, up from -12.0x today. This future PE is greater than the current PE for the US Software industry at 38.7x.
  • Analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 8.47%, as per the Simply Wall St company report.

Arteris Future Earnings Per Share Growth

Arteris Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • Arteris continues to operate at a net loss and projects a non-GAAP operating loss for the full year 2025 ($10.5 to $15.5 million), indicating ongoing challenges in achieving profitability and potential pressure on earnings and net margins if revenue growth falters or costs escalate.
  • The high concentration of large whale deals (such as the recent AMD agreement) exposes Arteris to customer concentration risk; if major customers reduce outsourcing, insource NoC IP, or switch providers, future revenues and cash flows could become volatile.
  • The increasing scale of R&D and field engineering investments, combined with only a gradual ramp in new product adoption, raises the risk that operating costs will outpace revenue growth, which could further suppress margins and delay a path to sustainable earnings.
  • The expansion of chiplet and heterogeneous integration technologies by mega-customers (like AMD using its own Infinity Fabric for coherent data, and only using Arteris for non-coherent applications) could lead to competitors or major chipmakers developing proprietary NoC solutions, diminishing Arteris' external market and negatively impacting long-term revenue growth.
  • Macroeconomic uncertainty (including FX fluctuations, global economic conditions, and possible geopolitical headwinds) can impact deal flow, OpEx (as seen recently with unfavorable USD/EUR movements), and delay sales cycles, all of which add risk to revenue predictability and margin expansion over time.

Valuation

How have all the factors above been brought together to estimate a fair value?
  • The analysts have a consensus price target of $14.0 for Arteris based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $16.0, and the most bearish reporting a price target of just $11.0.
  • In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $103.4 million, earnings will come to $14.0 million, and it would be trading on a PE ratio of 66.6x, assuming you use a discount rate of 8.5%.
  • Given the current share price of $9.31, the analyst price target of $14.0 is 33.5% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives